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Kathryn B. Garber1,*Growth Restriction in Individuals with a Paternally
Inherited IGF2 Mutation
Ahallmark of Russell-Silver syndrome (RSS) is the small size
of affected individuals. Growth retardation is evident pre-
natally and continues after birth. One of the genes misre-
gulated in RSS is IGF2, an imprinted gene that encodes in-
sulin-like growth factor II. Although believed to be central
to the small size of individuals with this syndrome,Mende-
lian mutations in this gene have not been described to
confirm this prediction—that is, until the recent paper by
Begemann et al., who identified related individuals who
appeared to have RSS but in whom RSS genetic testing
was negative. Exome sequencing revealed a nonsense
IGF2 variant that was present in all affected individuals
and obligate carriers. IGF2 is expressed only from the
paternal allele in most tissues, including the placenta.
Consistent with this, all four affected individuals inherited
the variant from their fathers, two of whom were them-
selves unaffected because they inherited the variant on
their unexpressed maternal allele.
Begemann et al. (2015). N. Engl. J. Med. 373, 349–356.
Curves, Not Cutoffs
There are distinct cutoffs and criteria for the diagnosis of
neurodevelopmental phenotypes, such as intellectual
disability and autism. This means that when one estimates
the penetrance of variation in a certain gene or genomic
region, an individual counts all or nothing for each of
these phenotypes. This approach to diagnosis ignores
the fact that in populations, these phenotypes exist as
continua. Invoking the threshold model of liability for
complex traits, if one adds a de novo rare pathogenic
copy-number variant (CNV) on an overall genomic profile
that would tend toward high intellectual function, such an
individual might be less likely to cross the diagnostic
demarcation for intellectual disability than one with the
same CNV but fewer of the favorable background variants.
In a recent article in Genetics in Medicine, David Ledbetter
and colleagues argue that we need to be cognizant of the
underlying continuum and take new approaches to assess-
ing families and presenting them with risk information.
This could involve assessing more than just the proband
in order to gauge the background neurodevelopmental
functioning of a family.
Finucane et al. (2015). Genet. Med. Published online July 9,
2015. http://dx.doi.org/10.1038/gim.2015.92.1Department of Human Genetics, Emory University School of Medicine, Atlan
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The AmericanHormones Influence Cancer Risk Due to Lynch
Syndrome
Women with Lynch syndrome are at an increased risk of
endometrial cancers; to date, the only consensus recom-
mendation for reducing this risk is hysterectomy. In gen-
eral populations of women, things that increase estrogen
levels and are unopposed by progesterone tend to increase
the risk of endometrial cancer. Dashti et al. used retrospec-
tive data from a family registry to explore whether the
same risk factors hold true in Lynch-syndrome-affected
women, who start out at a naturally higher risk of this
cancer. Would the mismatch-repair defect trump the
hormones? In fact, many of the hormone-related risk
associations that have been reported in general popu-
lations have been confirmed in the high-risk group.
Some of these factors, such as age at menarche, cannot
be controlled, but others, such as use of hormonal con-
traception, can. This result provides more information—
and more options to consider—for women with Lynch
syndrome.
Dashti et al. (2015). JAMA 314, 61–71.Increasingly Different
Mutation rates vary from genome to genome and even
within genomes. To explore contributions to this vari-
ability, Yang et al. identified de novo mutations through
comparisons of whole-genome sequences from parental
organisms and their progeny in Arabidopsis, rice, and
honeybees. This approach has been used to measure mu-
tation rates before, including in humans, but compari-
sons of different crosses made in the plants provide
new insight. Two parental inbred strains were each self-
crossed, generating homozygous progeny, and the muta-
tion rates from these crosses were compared to those
when heterozygous F1 individuals from an interstrain
cross were bred. In Arabidopsis, the authors observed a
3.5-fold higher rate of point mutations in the heterozy-
gous crosses than in the homozygous crosses. Mutation
rates correlated with heterozygosity, such that the muta-
tion rates were lower still in F3 and F4 crosses, and the
mutations that did occur tended to do so within the
remaining heterozygous domains. Although Yang et al.
haven’t yet explored the mechanism, this work indicates
that genetic diversity begets more diversity.
Yang et al. (2015). Nature 523, 463–467.ta, GA 30322, USA
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Incidental Findings of Cancer via NIPT
A handful of case reports describe the detection of
maternal cancer through abnormal results of noninvasive
prenatal testing (NIPT). Because the technology is based
on the quantification of cell-free DNA in the maternal
circulation, it has the potential to detect malignancies
that release these DNA fragments into circulation. Bianchi
et al. recently published the first large-scale look at this
incidental finding. Of more than 125,000 pregnant
women tested via NIPT, the authors were aware of ten in
whom malignancies were later diagnosed; three of these358 The American Journal of Human Genetics 97, 357–358, Septembdiagnoses resulted from testing triggered by the NIPT
result. NIPT is designed to detect single fetal aneuploidies.
With a cancer, it is more likely that multiple aneuploidies
will be present in the maternal circulation. Although the
data are incomplete because the authors relied on physi-
cians’ recontacting the laboratory when fetal results were
discordant with the NIPT results, the authors estimate
that there is a 20%–44% chance of maternal cancer when
multiple aneuploidies are present in the NIPT but not in
the fetus.
Bianchi et al. (2015). JAMA 314, 162–169.This Month in Our Sister JournalsGenetic Diversity Meets Social Disparities
Certain human populations are more genetically diverse
than others. In general, African populations are the
most diverse, and diversity gets lower for groups
geographically farther and farther away. When genetic
information is used in various contexts, it is easy to
ignore this fact and treat all groups similarly. Rosenberg
and Kang explore how differences in the level of genetic
diversity affect the application of genetic information
in various socially relevant settings. They describe the
impact of reduced diversity on false-positive rates inforensic identification via DNA and the decreased likeli-
hood of identifying a matched organ donor in a popu-
lation with increased genetic diversity. Finally, they
explore the logic behind the over-representation of
European populations in genome-wide association
studies and the issues that arise when methods devel-
oped for this group are applied to other populations
who differ in levels of genetic diversity and linkage
disequilibrium.
Rosenberg and Kang. (2015). Genetics. http://dx.doi.org/10.
1534/genetics.115.176750.er 3, 2015
